|
US6635632B1
(en)
|
1996-12-23 |
2003-10-21 |
Athena Neurosciences, Inc. |
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
US6552013B1
(en)
|
1998-06-22 |
2003-04-22 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
US6774125B2
(en)
|
1998-06-22 |
2004-08-10 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
US6958330B1
(en)
|
1998-06-22 |
2005-10-25 |
Elan Pharmaceuticals, Inc. |
Polycyclic α-amino-ε-caprolactams and related compounds
|
|
CA2324474A1
(en)
*
|
1998-06-22 |
1999-12-29 |
Elan Pharmaceuticals, Inc. |
Compounds for inhibiting beta-amyloid peptide release and/or its synthesis
|
|
EP1093372A4
(en)
*
|
1998-06-22 |
2004-09-29 |
Elan Pharm Inc |
CYCLIC AMINO ACID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND METHODS OF INHIBITING PEPTIDE RELEASE $ g (b) -AMYLOID AND / OR ITS SYNTHESIS USING THE SAME
|
|
EP1089981A1
(en)
*
|
1998-06-22 |
2001-04-11 |
Elan Pharmaceuticals, Inc. |
Compounds for inhibiting beta-amyloid peptide release and/or its synthesis.
|
|
US6509331B1
(en)
|
1998-06-22 |
2003-01-21 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
NZ509241A
(en)
|
1998-08-07 |
2003-08-29 |
Du Pont Pharm Co |
Succinoylamino lactams as inhibitors of alpha-beta protein production
|
|
HRP990246A2
(en)
|
1998-08-07 |
2000-06-30 |
Du Pont Pharm Co |
Succinoylamino benzodiazepines as inhibitors of a beta protein production
|
|
US6486350B1
(en)
|
1998-09-30 |
2002-11-26 |
Elan Pharmaceuticals Inc. |
Biological reagents and methods for determining the mechanism in the generation of β-amyloid peptide
|
|
AU778005B2
(en)
|
1998-12-24 |
2004-11-11 |
Bristol-Myers Squibb Pharma Company |
Succinoylamino benzodiazepines as inhibitors of Abeta protein production
|
|
KR100711840B1
(ko)
|
1999-01-22 |
2007-05-02 |
엘란 파마슈티칼스, 인크. |
Ｖｌａ-4 관련 질환 치료용 아실 유도체
|
|
US6503902B2
(en)
|
1999-09-13 |
2003-01-07 |
Bristol-Myers Squibb Pharma Company |
Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production
|
|
US6960576B2
(en)
|
1999-09-13 |
2005-11-01 |
Bristol-Myers Squibb Pharma Company |
Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
|
|
EP1218377A1
(en)
|
1999-10-08 |
2002-07-03 |
Bristol-Myers Squibb Pharma Company |
AMINO LACTAM SULFONAMIDES AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION
|
|
JP2003532656A
(ja)
|
1999-12-23 |
2003-11-05 |
ニューロケム インコーポレーティッド |
脳のアミロイド性脈管障害を調節するための化合物及び方法
|
|
CA2395862A1
(en)
|
2000-02-17 |
2001-08-23 |
Hong Liu |
Succinoylamino carbocycles and heterocycles as inhibitors of a.beta. protein production
|
|
CA2404023A1
(en)
|
2000-04-03 |
2001-10-11 |
Richard E. Olson |
Cyclic lactams as inhibitors of a.beta. protein production
|
|
WO2001074784A1
(en)
|
2000-04-03 |
2001-10-11 |
Dupont Pharmaceuticals Company |
CYCLIC LACTAMS AS INHIBITORS OF A-β PROTEIN PRODUCTION
|
|
WO2001077086A1
(en)
|
2000-04-11 |
2001-10-18 |
Dupont Pharmaceuticals Company |
SUBSTITUTED LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION
|
|
WO2001087354A2
(en)
|
2000-05-17 |
2001-11-22 |
Bristol-Myers Squibb Pharma Company |
Use of small molecule radioligands for diagnostic imaging
|
|
US6509333B2
(en)
|
2000-06-01 |
2003-01-21 |
Bristol-Myers Squibb Pharma Company |
Lactams substituted by cyclic succinates as inhibitors of Aβ protein production
|
|
US6432944B1
(en)
|
2000-07-06 |
2002-08-13 |
Bristol-Myers Squibb Company |
Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivatives
|
|
CN100471838C
(zh)
|
2000-12-28 |
2009-03-25 |
第一制药株式会社 |
Vla-4抑制剂
|
|
ZA200304059B
(en)
*
|
2000-12-28 |
2004-07-06 |
Daiichi Seiyaku Co |
VLA-4 inhibitors.
|
|
US20050159460A1
(en)
*
|
2001-12-04 |
2005-07-21 |
Elan Pharmaceuticals |
Peptide isosteres containing a heterocycle useful in the treatment of alzheimer's disease
|
|
TWI281470B
(en)
|
2002-05-24 |
2007-05-21 |
Elan Pharm Inc |
Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
|
|
TW200307671A
(en)
|
2002-05-24 |
2003-12-16 |
Elan Pharm Inc |
Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
|
|
US7459476B2
(en)
|
2002-06-27 |
2008-12-02 |
Elan Pharmaceuticals, Inc. |
Methods for treating Alzheimer's disease using hydroxyethylene compounds containing a heterocyclic amide bond isostere
|
|
FR2842523A1
(fr)
|
2002-07-17 |
2004-01-23 |
Sanofi Synthelabo |
Derives d'acylaminothiazole, leur preparation et leur application en therapeutique
|
|
WO2005009992A1
(ja)
|
2003-07-24 |
2005-02-03 |
Daiichi Pharmaceutical Co., Ltd. |
シクロヘキサンカルボン酸類
|
|
AU2006297220B8
(en)
|
2005-09-29 |
2013-01-31 |
Elan Pharmaceuticals, Inc. |
Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
DE602006020754D1
(de)
|
2005-09-29 |
2011-04-28 |
Elan Pharm Inc |
Carbamatverbindungen, die die durch vla-4 vermittelte leukozytenadhäsion inhibieren
|
|
TWI389904B
(zh)
|
2006-02-27 |
2013-03-21 |
Elan Pharm Inc |
抑制由ｖｌａ-４所調節的白血球黏附之嘧啶磺醯胺化合物
|